Le Lézard
Classified in: Health, Science and technology

Global Biomarker Technologies Market by Product, Technology, Application and Indication - Forecast to 2026 - ResearchAndMarkets.com

The "Biomarker Technologies Market by Product, Technology and Application, and Indication: Global Opportunity Analysis and Industry Forecast, 2019-2026" report has been added to ResearchAndMarkets.com's offering.

According to this report, the biomarker technologies market accounted for $21,594 million in 2018 is expected to reach $58,508 million by 2026, registering a CAGR of 13.2% from 2019 to 2026.

The key factors that drive the growth of the global biomarker technologies market are rise in prevalence of various diseases such as cancer, autoimmune diseases, and others. The other factors that contribute toward the growth of the market include surge in research related to drug discovery and increase in healthcare expenditure.

However, high initial investments for the discovery of biomarker can hamper the market growth to a certain extent. Whereas, surge in awareness associated with the need of early detection of various diseases such as cancers and high growth potential in emerging economies are anticipated to provide lucrative opportunities in the market during the forecast period.

On the basis of technology, the immunoassay segment was a major revenue contributor in 2018 and is expected to maintain its dominant position throughout the analysis period due to surge in prevalence of various diseases across the globe. For instance, the rise in prevalence of cancer contributes to the growth of biomarker technologies market as biomarkers serve as tools in diagnosis of cancer.

Moreover, other diseases such as diabetes type 1, is highly prevalent worldwide. This factor contributes toward the growth of the biomarker technologies market. In addition, infectious diseases such as AIDS, tuberculosis, and others are also diagnosed using biomarkers. Therefore, the factors above mentioned are responsible for the growth of this segment.

On the other side, next generation sequencing is expected to be the fastest growing segment during the forecast period as this technique is highly advantageous due to its property of differentiating between closely related tumor cells to provide better understanding of the growth of cancer. Moreover, the rise in research related to cancer worldwide is another factor that boosts the growth of this market.

According to product, the consumables segment accounted for the highest market share in 2018, and is anticipated to maintain this trend during the forecast period, as consumables form an important part of biomarker testing. Instrument segment is the fastest growing segment during the forecast period owing to the technological advancements.

In 2018, North America accounted for the major share of biomarker technologies market size and is expected to continue this trend owing to higher number of R&D activities, presence of skilled technicians, and wide availability of technologically advanced biomarker testing instruments and high prevalence of disease such as cancer, infectious diseases, neurological disorders, autoimmune diseases, and others. On the other side, Asia-Pacific is estimated to register the fastest growth during the forecast period.

The major companies profiled in this report include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Illumina, Inc., LI-COR, Inc., Merck KGAA, PerkinElmer Inc., QIAGEN, Shimadzu Corporation, and Thermo Fisher Scientific, Inc.

Key Findings of the Biomarker Technologies Market

For more information about this report visit https://www.researchandmarkets.com/r/yt1gyl

These press releases may also interest you

at 12:32
Pratt & Whitney, a division of United Technologies Corp. , today announced that GoAir has signed an agreement selecting the Pratt & Whitney GTFtm engine for the airline's order of 72 A320neo family aircraft. Pratt & Whitney will also provide GoAir...

at 12:30
Schneider Electric, the global leader in the digital transformation of energy management and automation, is recognized by the Financial Times Diversity Leaders 2020. Schneider Electric ranks 41st...

at 12:30
The best early Apple Black Friday 2019 deals are shown below, including price-drops and deals on Apple Watch, AirPods, iPad, iPhone, MacBook, iMac and Apple TV 4K.     Best Apple Watch deals: Save 50% off on Apple Watch Series 5 - save on Apple Watch...

at 12:26
Cybersecurity company CHEQ today announced the closing of $16 million in Series B funding from Battery Ventures and MizMaa Ventures, to further expand CHEQ's AI and Natural Language Processing (NLP) capabilities in combating ad fraud and ensuring...

at 12:22
CHERRY, a leading specialist of computer input devices, has released CHERRY KEYS, a free software tool for straightforward customization of keyboard and mice. The new CHERRY KEYS software program allows users to...

at 12:15
ID.me, the industry leader in secure online identification verification, today announced it has been named DC Inno's 2019 "50 on Fire" winner in the government category. The annual awards program celebrates the top 50 disruptors, luminaries and...

News published on 23 october 2019 at 04:10 and distributed by: